Nifty

:

22520.45

Sensex

:

72472.33

288.65 (1.30%)
879.09 (1.23%)

Login

Nifty
Sensex

:
:

22520.45
72472.33

288.65 (1.30%)
879.09 (1.23%)

Caplin Point Laboratories Ltd.

Pharmaceuticals & Drugs - Global

Rating :

74/99

BSE: 524742 | NSE: CAPLIPOINT

Watchlist

NSE BSE

2460.80

09-Oct-2026

Open
High
Low
Previous Close

2541
2576.4
2431.1
2548.80

Volume
Traded Value (lacs)
52 Week High
52 Week Low

188948
468395191.8
2990
1500.3

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

18,695.46
28.10
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

18,074.99
0.33%
5.09

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

18.47
11.50
8.89

EBITDA CAGR (%)

10 Years
5 Years
3 Years

19.81
14.04
6.65

PAT CAGR (%)

10 Years
5 Years
3 Years

20.96
16.42
11.95

P:E (Median)

8 Years
5 Years
3 Years

19.94
23.06
27.13

P:BV (Average)

8 Years
5 Years
3 Years

4.55
4.61
5.18

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.40
16.23
18.94

Earnings Forecasts:

(Updated: 03-10-2026)

Description 2026 2027 2028 2029
Adj EPS 84.36 95.75 110.85 -
P/E Ratio 29.17 25.70 22.20 -
Revenue 2187.19 2507.25 2834 -
EBITDA 760.85 871.3 1006.6 -
Net Income 641.24 732.05 851.85 -
ROA 17.68 20.82 20.78 -
P/B Ratio 5.33 4.24 3.83 -
ROE 20.4 17.48 17.42 -
FCFF 325.34 555.57 564.26 3360.18
FCFF Yield 1.65 2.81 2.85 17
Net Debt -1002.14 1825.1 1695.6 -
BVPS 462.01 581.01 643.01 -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 202.95 182.57 11.16% 191.36 173.61 10.22% 189.22 185.23 2.15% 175.18 207.93 -15.75%
Expenses 108.54 95.96 13.11% 107.77 98.57 9.33% 97.50 107.84 -9.59% 99.33 109.77 -9.51%
EBITDA 94.41 86.61 9.01% 83.59 75.04 11.39% 91.72 77.39 18.52% 75.85 98.16 -22.73%
EBIDTM 46.52% 47.44% 43.68% 43.22% 48.47% 41.78% 43.30% 47.21%
Other Income 62.79 32.03 96.03% 61.08 41.25 48.07% 31.73 28.83 10.06% 59.22 43.01 37.69%
Interest 0.05 0.04 25.00% 0.05 0.04 25.00% 0.07 0.04 75.00% 0.05 0.02 150.00%
Depreciation 6.56 6.14 6.84% 6.90 6.09 13.30% 6.37 6.01 5.99% 6.02 6.49 -7.24%
PBT 150.59 112.46 33.91% 137.72 110.16 25.02% 117.01 100.17 16.81% 129.00 134.66 -4.20%
Tax 30.21 26.57 13.70% 28.22 23.66 19.27% 29.73 25.46 16.77% 26.41 28.92 -8.68%
PAT 120.38 85.89 40.16% 109.50 86.50 26.59% 87.28 74.71 16.83% 102.59 105.74 -2.98%
PATM 59.32% 47.05% 57.22% 49.82% 46.13% 40.33% 58.56% 50.85%
EPS 15.84 11.30 40.18% 14.41 11.38 26.63% 11.48 9.83 16.79% 13.50 13.91 -2.95%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 610.36 510.22 19.63% 600.16 502.45 19.45% 542.77 492.96 10.10% 534.04 483.10 10.54%
Expenses 396.88 332.46 19.38% 395.92 334.39 18.40% 353.08 330.67 6.78% 344.87 318.34 8.33%
EBITDA 213.48 177.76 20.09% 204.24 168.06 21.53% 189.69 162.29 16.88% 189.17 164.76 14.82%
EBIDTM 34.98% 34.84% 34.03% 33.45% 34.95% 32.92% 35.42% 34.10%
Other Income 33.55 23.14 44.99% 28.36 25.74 10.18% 33.68 31.36 7.40% 30.37 20.77 46.22%
Interest 0.18 0.18 0.00% 0.36 0.17 111.76% 0.18 0.18 0.00% 0.16 0.21 -23.81%
Depreciation 21.62 16.29 32.72% 18.80 17.04 10.33% 19.28 16.20 19.01% 18.40 16.76 9.79%
PBT 225.23 184.43 22.12% 213.44 176.59 20.87% 203.91 177.27 15.03% 200.98 168.56 19.23%
Tax 46.13 33.70 36.88% 40.56 31.39 29.21% 38.03 37.19 2.26% 40.77 37.65 8.29%
PAT 179.10 150.73 18.82% 172.88 145.20 19.06% 165.88 140.08 18.42% 160.21 130.91 22.38%
PATM 29.34% 29.54% 28.81% 28.90% 30.56% 28.42% 30.00% 27.10%
EPS 23.28 20.11 15.76% 22.38 18.76 19.30% 21.56 18.28 17.94% 20.32 17.21 18.07%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 758.71 738.33 752.41 625.09 528.61 528.06 482.68 527.83 536.91 426.57 341.55 Net Sales Growth 1.25% -1.87% 20.37% 18.25% 0.10% 9.40% -8.55% -1.69% 25.87% 24.89% Cost Of Goods Sold 229.04 228.96 238.17 205.22 198.06 204.65 194.83 238.18 237.03 180.11 161.94 Gross Profit 529.67 509.37 514.24 419.87 330.55 323.41 287.85 289.65 299.87 246.46 179.61 GP Margin 69.81% 68.99% 68.35% 67.17% 62.53% 61.24% 59.64% 54.88% 55.85% 57.78% 52.59% Total Expenditure 413.14 400.55 420.44 338.01 309.23 308.58 273.14 320.83 348.31 284.60 247.72 Power & Fuel Cost - 13.64 14.11 15.43 9.89 9.54 6.36 7.19 12.29 10.96 9.85 % Of Sales - 1.85% 1.88% 2.47% 1.87% 1.81% 1.32% 1.36% 2.29% 2.57% 2.88% Employee Cost - 47.15 51.56 37.18 35.81 29.91 26.03 24.39 40.49 37.29 29.48 % Of Sales - 6.39% 6.85% 5.95% 6.77% 5.66% 5.39% 4.62% 7.54% 8.74% 8.63% Manufacturing Exp. - 64.79 63.82 54.17 42.18 34.68 27.15 33.34 38.72 37.02 28.34 % Of Sales - 8.78% 8.48% 8.67% 7.98% 6.57% 5.62% 6.32% 7.21% 8.68% 8.30% General & Admin Exp. - 21.61 22.48 18.24 13.52 12.55 7.25 11.70 17.00 14.11 12.59 % Of Sales - 2.93% 2.99% 2.92% 2.56% 2.38% 1.50% 2.22% 3.17% 3.31% 3.69% Selling & Distn. Exp. - 12.42 20.07 1.88 3.91 12.23 2.78 5.89 2.64 4.74 5.37 % Of Sales - 1.68% 2.67% 0.30% 0.74% 2.32% 0.58% 1.12% 0.49% 1.11% 1.57% Miscellaneous Exp. - 11.98 10.23 5.89 5.86 5.02 8.74 0.14 0.13 0.38 5.37 % Of Sales - 1.62% 1.36% 0.94% 1.11% 0.95% 1.81% 0.03% 0.02% 0.09% 0.05% EBITDA 345.57 337.78 331.97 287.08 219.38 219.48 209.54 207.00 188.60 141.97 93.83 EBITDA Margin 45.55% 45.75% 44.12% 45.93% 41.50% 41.56% 43.41% 39.22% 35.13% 33.28% 27.47% Other Income 214.82 195.37 134.59 105.84 99.54 56.69 23.01 65.97 35.40 23.59 12.51 Interest 0.22 0.20 0.12 0.10 0.12 0.09 0.17 0.19 0.50 0.52 0.50 Depreciation 25.85 25.43 24.77 27.08 25.65 25.77 22.44 19.65 20.84 18.99 13.26 PBT 534.32 507.52 441.67 365.74 293.15 250.31 209.94 253.12 202.65 146.05 92.58 Tax 114.57 110.94 102.18 82.03 58.89 62.44 53.71 55.49 54.49 43.74 22.26 Tax Rate 21.44% 21.86% 23.13% 22.43% 20.09% 24.95% 25.58% 21.92% 26.89% 29.95% 24.04% PAT 419.75 396.58 339.49 283.71 234.26 187.87 156.23 197.64 148.17 102.31 70.32 PAT before Minority Interest 419.75 396.58 339.49 283.71 234.26 187.87 156.23 197.64 148.17 102.31 70.32 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 55.32% 53.71% 45.12% 45.39% 44.32% 35.58% 32.37% 37.44% 27.60% 23.98% 20.59% PAT Growth 18.96% 16.82% 19.66% 21.11% 24.69% 20.25% -20.95% 33.39% 44.82% 45.49% EPS 55.23 52.18 44.67 37.33 30.82 24.72 20.56 26.01 19.50 13.46 9.25

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 2,287.33 2,187.19 1,937.47 1,694.10 1,466.73 1,269.41 1,061.29 863.20 648.69 539.84 401.65 Net Sales Growth 15.01% 12.89% 14.37% 15.50% 15.54% 19.61% 22.95% 33.07% 20.16% 34.41% Cost Of Goods Sold 915.64 865.68 770.84 724.18 663.21 557.51 471.74 413.16 288.78 238.18 184.93 Gross Profit 1,371.69 1,321.51 1,166.63 969.92 803.52 711.90 589.55 450.04 359.91 301.66 216.72 GP Margin 59.97% 60.42% 60.21% 57.25% 54.78% 56.08% 55.55% 52.14% 55.48% 55.88% 53.96% Total Expenditure 1,490.75 1,426.34 1,290.54 1,142.66 1,026.21 874.88 737.04 603.13 416.84 344.52 276.84 Power & Fuel Cost - 37.38 37.83 33.57 25.53 21.40 16.36 14.81 13.76 10.98 9.91 % Of Sales - 1.71% 1.95% 1.98% 1.74% 1.69% 1.54% 1.72% 2.12% 2.03% 2.47% Employee Cost - 198.58 184.06 142.66 136.12 114.74 101.97 67.15 45.58 37.61 29.71 % Of Sales - 9.08% 9.50% 8.42% 9.28% 9.04% 9.61% 7.78% 7.03% 6.97% 7.40% Manufacturing Exp. - 132.06 120.13 117.73 90.99 82.01 69.85 68.23 43.49 37.11 28.56 % Of Sales - 6.04% 6.20% 6.95% 6.20% 6.46% 6.58% 7.90% 6.70% 6.87% 7.11% General & Admin Exp. - 126.61 112.05 92.97 85.38 66.68 49.52 29.69 23.02 14.62 13.73 % Of Sales - 5.79% 5.78% 5.49% 5.82% 5.25% 4.67% 3.44% 3.55% 2.71% 3.42% Selling & Distn. Exp. - 53.35 55.34 24.88 18.78 27.52 18.03 9.95 2.08 5.92 9.41 % Of Sales - 2.44% 2.86% 1.47% 1.28% 2.17% 1.70% 1.15% 0.32% 1.10% 2.34% Miscellaneous Exp. - 12.68 10.29 6.67 6.20 5.02 9.57 0.14 0.13 0.10 9.41 % Of Sales - 0.58% 0.53% 0.39% 0.42% 0.40% 0.90% 0.02% 0.02% 0.02% 0.15% EBITDA 796.58 760.85 646.93 551.44 440.52 394.53 324.25 260.07 231.85 195.32 124.81 EBITDA Margin 34.83% 34.79% 33.39% 32.55% 30.03% 31.08% 30.55% 30.13% 35.74% 36.18% 31.07% Other Income 125.96 115.54 96.43 66.94 56.52 38.89 27.93 41.33 19.03 12.67 9.96 Interest 0.88 0.87 0.61 0.78 0.78 0.70 1.59 0.32 0.58 0.61 0.52 Depreciation 78.10 72.77 65.96 53.44 44.99 46.90 36.97 31.62 23.43 19.00 13.30 PBT 843.56 802.75 676.79 564.16 451.27 385.82 313.62 269.46 226.88 188.38 120.95 Tax 165.49 153.06 135.69 103.01 74.36 77.37 62.19 54.38 50.32 43.74 25.44 Tax Rate 19.62% 19.07% 20.05% 18.26% 16.48% 20.05% 19.83% 20.18% 22.18% 23.22% 21.03% PAT 678.07 641.24 536.31 457.09 376.26 299.84 242.27 215.00 176.56 144.78 95.61 PAT before Minority Interest 665.36 649.73 541.09 461.42 376.99 308.45 251.43 215.08 176.56 144.63 95.50 Minority Interest -12.71 -8.49 -4.78 -4.33 -0.73 -8.61 -9.16 -0.08 0.00 0.15 0.11 PAT Margin 29.64% 29.32% 27.68% 26.98% 25.65% 23.62% 22.83% 24.91% 27.22% 26.82% 23.80% PAT Growth 19.61% 19.57% 17.33% 21.48% 25.49% 23.76% 12.68% 21.77% 21.95% 51.43% EPS 89.22 84.37 70.57 60.14 49.51 39.45 31.88 28.29 23.23 19.05 12.58

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 2,050.50 1,700.93 1,390.15 1,139.91 930.65 758.67 599.91 432.04 295.60 200.12 Share Capital 15.20 15.20 15.19 15.18 15.16 15.13 15.13 15.13 15.12 15.12 Total Reserves 2,016.99 1,666.09 1,360.74 1,109.36 900.04 728.75 575.34 410.06 277.19 184.91 Non-Current Liabilities 17.07 13.70 13.29 16.42 24.63 24.99 27.16 24.77 27.86 19.90 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.29 0.32 0.48 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 2.21 0.85 0.43 0.00 0.00 0.00 0.00 0.00 0.00 0.40 Current Liabilities 144.17 99.85 118.87 146.85 98.88 77.33 64.26 82.51 87.34 97.05 Trade Payables 93.02 60.96 78.62 70.63 65.02 70.11 51.41 59.50 72.89 66.01 Other Current Liabilities 42.05 28.21 36.26 65.26 32.66 6.06 11.97 21.76 13.86 29.37 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 9.10 10.68 3.99 10.96 1.20 1.16 0.87 1.25 0.58 1.67 Total Liabilities 2,211.74 1,814.48 1,522.31 1,303.18 1,054.16 860.99 691.33 539.32 410.80 317.07 Net Block 222.92 205.26 165.79 156.85 162.46 182.68 166.93 137.77 169.32 151.75 Gross Block 422.24 381.41 318.45 285.13 268.64 266.22 228.35 179.85 231.63 195.07 Accumulated Depreciation 199.32 176.15 152.66 128.28 106.18 83.54 61.43 42.08 62.31 43.32 Non Current Assets 1,235.86 988.79 819.21 641.48 448.49 348.35 310.59 251.37 197.59 180.34 Capital Work in Progress 9.39 20.64 27.75 42.68 2.60 1.36 3.77 8.62 15.29 3.42 Non Current Investment 704.73 491.11 346.17 274.97 212.73 138.64 135.54 98.62 1.87 14.58 Long Term Loans & Adv. 284.98 257.13 272.07 164.70 70.70 5.67 4.36 6.36 11.11 10.59 Other Non Current Assets 13.84 14.65 7.43 2.28 0.00 20.00 0.00 0.00 0.00 0.00 Current Assets 975.88 825.69 703.10 661.70 605.67 512.64 380.74 287.95 213.21 136.73 Current Investments 342.51 311.33 237.98 210.18 51.97 10.54 60.23 69.62 46.34 4.20 Inventories 85.66 66.26 86.25 51.53 42.81 24.87 22.37 23.52 28.46 22.29 Sundry Debtors 265.96 175.33 128.67 88.24 53.73 98.46 218.98 125.39 86.35 3.21 Cash & Bank 206.08 214.71 215.78 271.38 316.08 345.49 58.27 44.85 28.28 76.66 Other Current Assets 75.67 30.70 14.68 2.17 141.08 33.28 20.89 24.56 23.78 30.37 Short Term Loans & Adv. 29.70 27.36 19.74 38.20 129.11 14.97 10.57 15.95 17.00 23.05 Net Current Assets 831.71 725.84 584.23 514.85 506.79 435.31 316.48 205.44 125.87 39.67 Total Assets 2,211.74 1,814.48 1,522.31 1,303.18 1,054.16 860.99 691.33 539.32 410.80 317.07

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 3,586.42 2,850.49 2,315.71 1,880.48 1,483.93 1,185.83 947.91 632.91 363.83 224.76 Share Capital 89.78 89.78 89.77 89.76 89.74 89.71 89.71 51.05 15.12 15.12 Total Reserves 3,478.34 2,741.06 2,211.72 1,775.35 1,378.74 1,081.33 848.76 575.01 345.42 209.56 Non-Current Liabilities 20.75 13.24 7.89 2.13 12.55 17.39 24.86 23.42 27.86 19.90 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.29 0.32 0.48 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.00 1.74 9.04 7.78 8.48 5.69 5.23 0.13 0.00 0.40 Current Liabilities 385.96 305.99 330.85 268.00 207.68 142.85 144.32 86.11 108.67 113.36 Trade Payables 296.03 217.58 229.62 152.56 155.94 88.50 64.14 60.47 94.23 78.60 Other Current Liabilities 69.34 64.28 90.29 99.94 48.68 51.87 79.28 24.20 13.86 33.09 Short Term Borrowings 0.57 0.55 0.28 3.41 0.50 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 20.02 23.58 10.66 12.09 2.56 2.48 0.91 1.44 0.58 1.67 Total Liabilities 4,037.51 3,205.62 2,685.57 2,177.40 1,730.11 1,363.61 1,125.75 742.52 500.45 358.38 Net Block 580.01 545.78 452.66 279.81 286.57 305.34 272.50 226.84 169.48 151.83 Gross Block 964.68 859.07 702.31 480.32 445.74 422.58 354.79 271.51 231.79 195.15 Accumulated Depreciation 384.67 313.29 249.65 200.51 159.17 117.24 82.29 44.67 62.31 43.31 Non Current Assets 1,451.85 1,071.67 792.65 625.21 432.29 349.04 303.23 248.83 196.34 179.16 Capital Work in Progress 233.58 143.50 116.62 220.71 17.73 13.88 20.12 9.70 15.29 3.42 Non Current Investment 473.31 279.13 137.63 70.52 37.01 0.66 0.56 0.33 0.33 13.24 Long Term Loans & Adv. 151.11 88.61 78.31 51.51 89.90 7.92 10.05 11.95 11.23 10.67 Other Non Current Assets 13.84 14.65 7.43 2.66 1.08 21.24 0.00 0.00 0.00 0.00 Current Assets 2,585.66 2,133.95 1,892.92 1,552.19 1,297.82 1,014.57 822.53 493.69 304.11 179.22 Current Investments 385.71 311.33 237.98 210.18 51.97 10.54 60.23 69.62 46.34 4.20 Inventories 428.86 336.10 363.04 288.22 227.31 179.01 238.23 37.45 28.46 22.29 Sundry Debtors 825.81 632.49 542.72 394.06 317.05 279.36 228.96 159.81 125.88 33.02 Cash & Bank 621.04 591.41 552.74 493.48 462.99 438.33 223.43 152.99 79.28 93.07 Other Current Assets 324.24 77.11 50.43 22.82 238.50 107.33 71.68 73.83 24.16 26.63 Short Term Loans & Adv. 226.32 185.51 146.01 143.43 224.89 87.08 56.81 64.61 17.28 19.31 Net Current Assets 2,199.70 1,827.96 1,562.07 1,284.19 1,090.14 871.72 678.21 407.58 195.44 65.86 Total Assets 4,037.51 3,205.62 2,685.57 2,177.40 1,730.11 1,363.61 1,125.76 742.52 500.45 358.38

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 203.48 195.87 111.01 157.10 230.97 294.64 87.01 107.34 22.61 55.49 PBT 507.52 441.67 365.74 293.15 250.31 209.94 253.12 202.65 146.05 92.58 Adjustment -143.81 -84.47 -68.57 -59.57 -19.43 7.75 -32.58 -0.29 3.44 8.06 Changes in Working Capital -50.82 -57.49 -99.07 -11.45 62.07 131.85 -83.19 -54.17 -92.59 -24.76 Cash after chg. in Working capital 312.89 299.71 198.10 222.13 292.95 349.54 137.36 148.19 56.90 75.88 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -109.41 -103.84 -87.09 -65.03 -61.98 -54.90 -50.35 -40.84 -34.29 -20.39 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -213.47 -140.20 -118.94 -86.67 -275.93 -3.71 -41.06 -76.51 -59.71 -37.07 Net Fixed Assets -29.58 -55.85 -18.39 -56.57 -3.66 -35.46 -43.65 58.45 -48.43 -19.56 Net Investments -244.80 -218.29 -99.00 -220.45 -115.52 46.59 -27.53 -120.03 -29.43 -17.35 Others 60.91 133.94 -1.55 190.35 -156.75 -14.84 30.12 -14.93 18.15 -0.16 Cash from Financing Activity -45.81 -38.10 -34.26 -30.42 -22.76 -3.47 -32.92 -15.21 -11.60 -6.74 Net Cash Inflow / Outflow -55.80 17.57 -42.19 40.01 -67.72 287.46 13.03 15.62 -48.70 11.67 Opening Cash & Equivalents 99.64 80.64 122.02 81.01 148.82 55.61 42.52 26.18 74.89 63.22 Closing Cash & Equivalent 44.09 99.64 80.64 122.02 81.01 342.88 55.61 42.52 26.18 74.89

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 523.24 432.37 318.39 271.37 336.73 268.61 44.68 83.42 66.49 67.61 PBT 802.79 676.78 564.43 451.35 385.82 313.62 269.46 226.88 188.38 120.95 Adjustment -26.08 5.51 2.40 11.77 30.44 23.09 7.09 19.12 14.84 8.61 Changes in Working Capital -108.97 -122.28 -139.44 -103.75 1.96 -1.96 -177.11 -120.06 -100.38 -38.39 Cash after chg. in Working capital 667.74 560.01 427.39 359.37 418.22 334.75 99.44 125.94 102.84 91.16 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -144.50 -127.64 -109.00 -88.00 -81.49 -66.14 -54.76 -42.51 -36.35 -23.55 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -582.30 -334.73 -320.04 -217.58 -376.77 -29.44 -54.50 -100.46 -69.02 -36.11 Net Fixed Assets -29.58 -55.85 -18.39 -56.57 -3.66 -35.46 -43.65 58.45 -48.43 -19.56 Net Investments -244.80 -218.29 -99.00 -220.45 -115.52 46.59 -27.53 -120.03 -29.43 -17.35 Others -307.92 -60.59 -202.65 59.44 -257.59 -40.57 16.68 -38.88 8.84 0.80 Cash from Financing Activity -46.46 -38.32 -38.07 -28.17 -40.68 -23.98 79.77 89.79 -11.60 -6.74 Net Cash Inflow / Outflow -105.52 59.32 -39.72 25.62 -80.72 215.19 69.94 72.76 -14.13 24.76 Opening Cash & Equivalents 199.45 138.70 177.56 150.76 231.57 220.77 150.65 77.17 91.31 66.55 Closing Cash & Equivalent 86.64 193.74 134.20 170.92 150.76 435.72 220.77 150.65 77.17 91.31

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 267.39 221.22 181.16 148.16 120.74 98.33 78.06 56.22 38.66 26.47 ROA 19.70% 20.35% 20.08% 19.87% 19.62% 20.13% 32.12% 31.19% 28.11% 24.26% ROE 21.36% 22.21% 22.69% 22.97% 22.65% 23.42% 38.92% 41.30% 41.56% 43.57% ROCE 27.07% 28.58% 28.92% 28.33% 29.64% 30.92% 49.05% 55.76% 58.99% 56.89% Fixed Asset Turnover 1.84 2.15 2.07 1.91 1.97 1.95 2.59 2.61 2.00 1.83 Receivable days 109.08 73.74 63.33 49.01 52.60 120.02 119.07 71.97 38.32 5.35 Inventory Days 37.55 36.99 40.23 32.57 23.39 17.86 15.87 17.67 21.71 21.48 Payable days 122.73 106.95 132.73 124.99 120.50 113.83 61.02 67.67 86.81 85.61 Cash Conversion Cycle 23.89 3.77 -29.17 -43.41 -44.52 24.05 73.91 21.97 -26.78 -58.79 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 2538.60 3681.58 3658.40 2443.92 2782.22 1235.94 1369.24 404.61 281.22 185.02

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 459.68 362.67 293.21 235.91 183.89 144.94 114.21 78.03 47.69 29.73 ROA 17.94% 18.37% 18.98% 19.30% 19.94% 20.20% 23.02% 28.41% 33.68% 30.54% ROE 20.79% 21.72% 22.97% 23.68% 24.77% 25.65% 29.58% 37.14% 49.43% 54.97% ROCE 24.97% 26.22% 26.92% 26.85% 28.77% 28.82% 33.35% 45.59% 64.08% 69.03% Fixed Asset Turnover 2.40 2.48 2.87 3.17 2.92 2.73 2.76 2.58 2.53 2.14 Receivable days 121.68 110.70 100.92 88.48 85.74 87.41 82.19 80.37 53.72 18.62 Inventory Days 63.83 65.86 70.16 64.15 58.42 71.75 58.28 18.54 17.16 18.68 Payable days 108.28 105.88 96.31 84.89 80.02 59.05 28.33 65.76 89.68 88.17 Cash Conversion Cycle 77.23 70.68 74.76 67.73 64.14 100.11 112.15 33.15 -18.80 -50.88 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.01 0.04 0.00 0.00 0.00 Interest Cover 923.75 1110.48 724.63 579.65 552.17 198.25 843.86 391.22 309.72 235.08

Top Investors:

investor education and protection fund authority ministry of corporate affairs

uti multi cap fund

pinebridge global funds - pinebridge india equity fund

Annual Reports:

News Update:

USFDA completes inspection at Tamil Nadu facility of Caplin Point’s arm
22nd Aug 2026, 11:11 AM

At the end of the inspection, the company received Form 483 with 10 observations
Read More
Caplin Point Labs. - Quarterly Results
13th Aug 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback